by | Jan 27, 2023 | Uncategorized
A phase 3 trial of ciltacabtagene autoleucel for adults with relapsed or refractory multiple myeloma met its primary endpoint, according to the agent’s manufacturer.Ciltacabtagene autoleucel (Carvykti; Janssen, Legend Biotech) — often called cilta-cel — is a B-cell...
by | Jan 23, 2023 | Uncategorized
A plant-based diet appeared associated with sustained minimal residual disease negativity among a cohort of patients with multiple myeloma, according to study results.The findings, published in Clinical Cancer Research, provide rationale to further assess a...
by | Jan 10, 2023 | Uncategorized
Source: Cure Today articles Although there is no cure for myeloma, the prognosis can be good if doctors catch it early. Read More
by | Jan 10, 2023 | Uncategorized
NEW ORLEANS — A novel combination induced response among patients with pretreated multiple myeloma, according to study results presented at ASH Annual Meeting and Exposition.The regimen — which consisted of teclistamab (JNJ-64007957, Janssen), subcutaneous daratumumab...
by | Jan 9, 2023 | Uncategorized
Source: Cure Today articles If you were to meet Dr. Sundar Jagannath in a crowded room, you would not assume that he is one of the greatest myeloma doctors of all time. Read More
by | Jan 8, 2023 | Uncategorized
Source: Cure Today articles Through Dr. Frits van Rhee’s patient care and research, he has made a significant impact on improving the lives of those affected by multiple myeloma. Read More